Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Alphabet's recent AI progress and Waymo expansion signal growth potential. Learn why GOOG stock is trading cheap and could be ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

Alphabet's AI investments have been focused on improving its advertising offerings. Google Cloud is a significant growth driver for the company. The stock is cheaper than many of the biggest stock ...

Alphabet’s new Gemini 2.5 Pro model has surpassed rival AI systems, earning top scores on major benchmarks and excelling in coding and reasoning tasks. Its advantage comes from a trifecta of ...

Sundar Pichai is the CEO of Google as well as its parent company Alphabet, which he’s led as an AI-first company for several years. He speaks with HBR Editor at Large Adi Ignatius about shaping ...

We recently published a list of GTC Recap and Beyond: 10 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOG) stands against other AI ...

Koray Kavukcuoglu, CTO of Google DeepMind, announced in a blog post: “Today we’re introducing Gemini 2.5, our most intelligent AI model ... to [email protected] Alphabet NewsMORE Related ...